Singapur - anglès - HSA (Health Sciences Authority)

ge healthcare pte. ltd. - ioflupane (123i) - injection, solution - ioflupane (123i) 74 mbq/ml at reference time

Filipines - anglès - FDA (Food And Drug Administration)

pan-ject pharma'l corp - aztreonam - powder for injection im/iv/iv infusion - 1g

Filipines - anglès - FDA (Food And Drug Administration)

pan-ject pharma'l corp - clarithromycin (as lactobionate) - lyophilized powder for injection iv - 500mg

Filipines - anglès - FDA (Food And Drug Administration)

pan-ject pharma'l corp - furosemide - solution for injection im/iv - 10mg/ml (20mg/ml)

Filipines - anglès - FDA (Food And Drug Administration)

pan-ject pharma'l corp - meloxicam - solution for injection - 15mg/1.5ml

Filipines - anglès - FDA (Food And Drug Administration)

pan-ject pharma'l corp - phytomesodiumdione - emulsion for injection im/iv/sc - 10mg/ml

Filipines - anglès - FDA (Food And Drug Administration)

pan-ject pharma'l corp - rocuronium bromide - solution for injection iv - 10mg/ml

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

curium pharma uk ltd - ioflupane [i-123] - solution for injection - 74mbq/1ml

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

curium pharma uk ltd - ioflupane [i-123] - solution for injection - 74mbq/1ml

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - triamcinolone acetonide, quantity: 10 mg/ml - injection, suspension - excipient ingredients: carmellose sodium; polysorbate 80; benzyl alcohol; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - intra-articular: kenacort-a 10 injection (sterile triamcinolone acetonide suspension usp) is indicated for intra-articular or intrasynovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute non-specific tenosynovitis, post-traumatic osteoarthritis. intradermal: intralesional administration of kenacort-a 10 injection is indicated for the treatment of keloids, discoid lupus erythermatous, necrobiosis lipoidica diabeticorum, alopecia areata and localised hypertrophic, infiltrated, inflammatory lesions of: lichen planus, psoriatic plaques, granuloma annulare, and lichen simplex chronicus ( neurodermatitis), kenacort-a 10 injection also may be useful in cystic tumours of an aponeurosis or tendon ( ganglia).